Skip to content

Public FDA record

Z-0831-2015: Integra Licox Brain Tissue Oxygen Monitoring Integra Licox Recon Tissue Oxygen Monitoring 1) LICOX Compl

Recall record Z-0831-2015 for Integra LifeSciences Corp.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0831-2015
Company in FDA record
Integra LifeSciences Corp.
FDA classification date
Dec 18, 2014
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Due to a complaint, it was determined that multiple lots of Licox catheters manufactured since October 29, 2013 contained a smart card which was programmed with an inaccurate lkN2 value.

Source facts

Action
Integra sent Urgent- Voluntary Medical Device Recall Letters/Recall Acknowledgement and Return Form dated 11/7/2014 to customers and distributors via traceable courier service.
Initiated
2014-11-07
Root cause
Device Design
Terminated
2015-08-11
Distribution
Nationwide, Foreign
Recall number
Z-0831-2015
Recall status
Terminated
CDRH record ID
131571
FDA classified
2014-12-18
Recall event number
69803

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗